The board of directors of Immunotech Biopharm Ltd. hereby announced that with effect from 25 August 2023, Mr. Wang Donghu (Mr. Wang) has been appointed as a non- executive Director. Mr. Wang Donghu, aged 68, graduated from Renmin University of China with a master's degree of business administration in 2003. Mr. Wang has over 20 years of experience in pharmaceutical and biotechnology industries in the People's of Republic of China (PRC).

Since 2003, he has held a number of senior management positions in Boai NKY Medical Technologies Group Ltd., a PRC based company listed on the Shenzhen Stock Exchange and currently serves as a director of NKY Medical. The Board further announced that Mr. Si Xiaobing (Mr. Si) has resigned from his position as a non-executive Director with effect from 25 August 2023, due to his other personal commitments. Mr. Si has confirmed that he has no disagreement with the Board and there are no other matters with respect to his resignation that need to be brought to the attention of the Shareholders or The Stock Exchange of Hong Kong Limited.